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Abstract
Background: Maternal mortality is too rare in high income countries to be used as a marker of
the quality of maternity care. Consequently severe maternal morbidity has been suggested as a
better indicator. Using the maternal morbidity outcome indicator (MMOI) developed and validated
for use in routinely collected population health data, we aimed to determine trends in severe
adverse maternal outcomes during the birth admission and in particular to examine the
contribution of postpartum haemorrhage (PPH).
Methods: We applied the MMOI to the linked birth-hospital discharge records for all women who
gave birth in New South Wales, Australia from 1999 to 2004 and determined rates of severe
adverse maternal outcomes. We used frequency distributions and contingency table analyses to
examine the association between adverse outcomes and maternal, pregnancy and birth
characteristics, among all women and among only those with PPH. Using logistic regression, we
modelled the effects of these characteristics on adverse maternal outcomes. The impact of adverse
outcomes on duration of hospital admission was also examined.
Results: Of 500,603 women with linked birth and hospital records, 6242 (12.5 per 1,000) suffered
an adverse outcome, including 22 who died. The rate of adverse maternal outcomes increased from
11.5 in 1999 to 13.8 per 1000 deliveries in 2004, an annual increase of 3.8% (95%CI 2.3–5.3%). This
increase occurred almost entirely among women with a PPH. Changes in pregnancy and birth
factors during the study period did not account for increases in adverse outcomes either overall,
or among the subgroup of women with PPH. Among women with severe adverse outcomes there
was a 12% decrease in hospital days over the study period, whereas women with no severe adverse
outcome occupied 23% fewer hospital days in 2004 than in 1999.
Conclusion: Severe adverse maternal outcomes associated with childbirth have increased in
Australia and the increase was entirely among women who experienced a PPH. Reducing or
stabilising PPH rates would halt the increase in adverse maternal outcomes.
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Background
Maternal deaths in childbirth have declined in high-
income countries such that they are now rare occurrences
(<10/100,000 livebirths) [1-3]. As mortality has tradition-
ally been used as an indicator of the quality of health care,
severe maternal morbidity has been suggested as a better
indicator of the quality of maternity care [4-10]. Obstetric
haemorrhage is the single most important cause of both
maternal mortality and severe morbidity worldwide
[4,10-12]. Increasing rates of postpartum haemorrhage
(PPH), and maternal deaths attributable to PPH, have
been reported in Australia, Canada and the United King-
dom [2,13,14].
Assessment of severe maternal morbidity has relied on
intensive methods of data collection in single hospitals or
limited populations [15]. Composite measures of severe
maternal morbidity based on routinely collected popula-
tion health data have been used occasionally [4,8]. Com-
posite population-level measures of severe morbidity help
overcome problems such as under-ascertainment of indi-
vidual adverse events and random fluctuations in the
component events, and provide an overall count of mater-
nal morbidity in childbirth that is not tied to specific con-
ditions or modes of care [11]. To date however, studies
utilising population health data have relied on maternal
morbidity measures that have not been validated and
have included outcomes that may not be reliably reported
[4,8].
The maternal morbidity outcome indicator (MMOI) is a
validated measure of severe adverse outcomes associated
with childbirth which was developed for use in popula-
tion health data. [11]. The MMOI is a composite indicator
which uses information on diagnoses and procedures
from birth and hospital discharge data (see Table 1)
which together, accurately and reliably identify women
who suffered a severe adverse outcome at the time of
Table 1: Frequency of diagnoses and procedures contributing to the maternal morbidity outcome indicator (MMOI) during the birth 
admission 1999–2004
Indicators of severe maternal morbidity Frequency* Rate/10 000
Morbid events/diagnoses† 1340
Shock 321 6.41
Uterine rupture 265 5.29
Cardiac failure 225 4.49
Obstetric embolism 194 3.88
Acute renal failure 105 2.10
Major complication of anaesthesia 95 1.90
Psychosis 29 0.58
Status asthmaticus 21 0.42
Status epilepticus 19 0.38
Acute appendicitis 18 0.36
Cerebrovascular accident 16 0.32
Procedures indicating morbidity† 6320
Any transfusion‡ 4710 94.1
Blood transfusion 4552 90.9
Transfusion of other blood products 612 12.4
Procedures to control bleeding
Evacuation haematoma 306 6.11
Hysterectomy 156 3.12
Dilatation and curettage with GA 155 3.10
Embolisation or ligation of blood vessels 40 0.80
Other interventions to control post-operative bleeding 48 0.96
Other procedures
Assisted ventilation 132 2.64
Repair bladder 113 2.26
Repair ruptured uterus 66 1.32
Cystostomy 64 1.28
Reclose disrupted CS wound 24 0.48
Repair small or large intestine 18 0.36
Dialysis 17 0.34
*women can have more than one diagnosis and/or procedure.
† Total includes diagnoses and procedures with ≤ 10 events including, myocardial infarction, cerebral oedema, peritonitis, disseminated 
intravascular coagulopathy, sickle cell anaemia with crisis and repair of inverted uterus.
‡ Includes transfusion of blood or blood products (eg platelets, coagulation factors).
GA = general anaesthesiaBMC Pregnancy and Childbirth 2009, 9:7 http://www.biomedcentral.com/1471-2393/9/7
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childbirth. It is a broad measure of adverse maternal out-
come (eg hysterectomy, renal failure) rather than causal
conditions (eg haemorrhage, preeclampsia). Although
clinical studies may be able to identify 'near miss' morbid-
ity (events where the woman almost died) [6,7,16], pop-
ulation health data lack the clinical detail necessary to
draw such a conclusion with confidence. The MMOI iden-
tifies adverse outcomes from the severe end of the mor-
bidity spectrum with a broader remit than 'near miss'
morbidity [11]. The MMOI was developed as a tool for
assessing the quality of maternity care and does not
include factors that might be directly linked to service pro-
vision, such as intensive care unit admission. The aim of
this study is to determine trends in severe adverse mater-
nal outcomes during the birth admission using the MMOI
and, in particular, to examine the contribution of postpar-
tum haemorrhage.
Methods
Study population
The study population included all women who gave birth
in New South Wales (NSW) hospitals from 1 January
1999 to 31 December 2004. NSW is the most populous
state in Australia with ~6.8 million people and approxi-
mately one-third of all Australian births in over 100 hos-
pitals. During the study period only 0.1% of women had
home births [17].
Data sources
The population health data for this study were obtained
from two validated, NSW Department of Health compu-
terised datasets: 'birth data' from the Midwives Data Col-
lection and 'hospital data' from the Admitted Patients
Data Collection [18]. The birth data are collected in a leg-
islated population-based surveillance system covering all
births ≥ 20 weeks' gestation or ≥ 400 g birthweight. Infor-
mation on maternal characteristics, pregnancy, labour,
delivery and infant outcomes are reported by the attend-
ing midwife or doctor. Hospital data are a census of all
NSW inpatient hospital discharges (public and private);
diagnoses and procedures are coded for each admission
from the medical records according to the 10th revision of
the International Statistical Classification of Diseases and
Related Health Problems, Australian Modification (ICD-
10-AM) and the affiliated Australian Classification of
Health Interventions [19]. The NSW Department of
Health performed record linkage of the two datasets, and
provided anonymised, linked birth and hospital data for
the birth admission. Over 98% of birth records link to a
hospital discharge record [18].
Women with any of the diagnoses or procedures that
make up the maternal morbidity outcome indicator
(MMOI) recorded in their hospital data were considered
to have suffered a severe adverse outcome during the birth
admission [11]. Data from 21 diagnosis and 20 procedure
fields in each medical record were included as this was the
maximum number of fields available in 1999. The MMOI
does not include factors that predispose women to
adverse outcomes, such as preeclampsia and haemor-
rhage. Instead adverse consequences of these conditions
are included, such as acute renal failure, disseminated
intravascular coagulopathy and blood transfusions (Table
1).
Information on sociodemographic and pregnancy risk
factors for maternal morbidity was obtained from the
birth and/or hospital data. Only factors (listed in Tables 2
and 3) that are well and accurately reported in birth and/
or hospital data were included in the analysis [20-25].
Birth data provided information on pregnancy and birth
characteristics, such as plurality, parity, duration of preg-
nancy at first antenatal visit, smoking status during preg-
nancy, labour and delivery characteristics and maternal
death. Hospital data provided information on the dura-
tion of the hospital stay and on ICD10-AM diagnoses and
procedures. Postpartum haemorrhage (PPH) was defined
according to ICD10-AM as a haemorrhage of 500 ml or
more following vaginal delivery or 750 ml or more fol-
lowing a caesarean delivery resulting in a recorded clinical
diagnosis of PPH and identified during the birth hospital-
isation from the hospital data [19]. PPH in the hospital
data is reported with 74% sensitivity and 99% specificity
when compared with the medical record [21]. Only severe
PPH (requiring transfusion, procedures to control bleed-
ing and/or resulting in organ failure) was included as an
adverse maternal outcome (Table 1).
Analyses
First we examined changes in the frequency of maternal
and pregnancy characteristics from 1999 to 2004. For
characteristics that changed significantly over time (χ2 for
linear trend P < 0.01) we calculated the absolute change
in the rate in 2004 relative to 1999. We determined the
rate of adverse maternal outcomes, both overall and
among women with PPH, per 1000 women giving birth.
We developed two logistic regression models for adverse
maternal outcomes, one among all women and one
among only those with PPH. The aim of the first model
was to examine whether any change in the rate of adverse
outcomes over time was due solely to changes in known
pregnancy and birth factors. As severe adverse maternal
outcomes are rare, annual change in the rate from 1999 to
2004 was estimated from the odds ratio (OR) for 'year'
derived from this first logistic regression model. The aim
of the second model was to examine risk factors for
adverse maternal outcome among women with PPH and
whether they accounted for changes over time. Pregnancy
and birth factors were included in both initial models ifBMC Pregnancy and Childbirth 2009, 9:7 http://www.biomedcentral.com/1471-2393/9/7
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the Wald chi-squared test gave P < 0.1. Least significant
factors were progressively eliminated from each initial
model, only being retained if they had P < 0.01 or if they
were confounders (change in OR of 10% or more). Crude
and adjusted odds ratios (aOR) and 95 percent confi-
dence intervals (95% CI) were calculated from the regres-
sion coefficients and their standard errors. Although the
models include some factors that may lie on the causal
pathway to adverse outcomes, (e.g. previous caesarean
section, antepartum haemorrhage due to placenta praevia
and caesarean section in the index pregnancy [26]), the
causal pathways are multifactorial and the factors are also
independent risk factors for adverse outcomes. As our aim
was to see if changes in any of the risk factors accounted
for changes in adverse outcomes over time, we chose an
inclusive model. Consequently, the adjusted odds ratios
for the more distal risk factors may be under-estimated.
Finally, we examined the impact of adverse maternal out-
comes on maternal length of stay during the birth admis-
sion as a measure of health service impact. We determined
the total number of hospital bed days for women with
and without an adverse outcome and calculated the abso-
lute and percentage change over the study period. The
Table 2: Trends in maternal population characteristics, NSW 1999–2004
Maternal and pregnancy characteristics 1999 N = 84934% 2004 N = 81381 Change in rate relative to 1999%(95%CI)*
Maternal age
<20 years 4.8 4.0 -15.5 (-19.6, -11.4)
20–34 years 78.2 76.0 -2.8 (-3.3, -2.3)
≥ 35 years 17.0 19.9 +17.0 (+14.8, +19.2)
Parity
0 41.2 42.5 + 3.3 (+ 2.2, + 4.5)
1–3 55.4 54.0 -2.5 (-3.4, -1.6)
≥ 43 . 5 3 . 5 -
Smoking 18.9 14.8 -21.9 (-23.8, -20.0)
Delivery hospital (level)
Small rural 12.1 10.2 -15.6 (-18.1, -13.1)
District 29.4 25.8 -12.3 (-13.8, -10.8)
Tertiary obstetric 40.2 39.6 -1.3 (-2.5, -0.1)
Private 18.3 24.4 +33.0 (+30.8, +35.1)
Multiple pregnancy 1.5 1.6 -
Previous caesarean birth† 18.3 22.6 +23.7 (+20.9, +26.4)
Hypertensive disorders 10.9 8.9 -18.1 (-20.7, -15.5)
Preexisting hypertension 0.6 0.6 +12.3 (+ 8.1, +25.4)
Pregnancy Hypertension 10.3 8.2 -20.2 (-22.9, -17.5)
Diabetes during pregnancy 4.3 4.9 +13.9 (+ 9.2, +18.6)
Pre-existing diabetes 0.3 0.4 -
Gestational diabetes 4.0 4.6 +13.5 (+ 8.6, +18.3)
Antepartum haemorrhage 1.6 1.8 +11.7 (+ 4.0, +19.3)
Induction of labour‡ 26.8 28.8 +7.5 (+ 5.7, + 9.2)
Mode of delivery
Spontaneous vaginal 69.4 62.4 -10.0 (-10.7, -9.4)
Instrumental 10.9 10.3 -5.8 (-8.5, -3.1)
Caesarean section 19.7 27.3 +38.5 (+36.4, +40.5)
Postpartum haemorrhage 6.2 6.8 +10.7 (+ 6.9, +14.6)
* Changes with a significant trend over time χ2 for trend P < 0.01 are reported.
† among who had prior births.
‡ Excludes caesarean sections prior to labour.BMC Pregnancy and Childbirth 2009, 9:7 http://www.biomedcentral.com/1471-2393/9/7
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study was approved by the Sydney South West Area
Health Service Human Research Ethics Committee and
the University of Sydney Human Ethics Research Com-
mittee.
Results
From 1999 to 2004, the number of women giving birth in
NSW decreased by 4.2%, from 84,934 in to 81,381. There
were also significant changes in the characteristics of
women giving birth during the study period, including
some which are recognised risk factors for adverse mater-
nal outcomes (Table 2). For example there were signifi-
cant increases in women aged ≥ 35 years, women having
first births, and women with a prior caesarean section,
and in antepartum and postpartum haemorrhage rates.
Births in rural and district hospitals declined, as did the
average length of the birth admission from 4.3 to 3.4 days.
Of the 500,603 women giving birth between 1999 and
2004, the MMOI identified 6242 (12.5 per 1000) as suf-
fering severe adverse outcomes, including 22 women who
died in hospital. The MMOI component diagnoses and
procedures and their rates per 10,000 deliveries are
reported in Table 1. Morbid procedures were more com-
monly reported than morbid diagnoses; 5359 (85.8%)
women underwent one or more procedures, and 1255
Table 3: Risk factors for adverse maternal outcome among 31,269 women with a postpartum haemorrhage
Maternal morbidity
Yes N = 3745% No N = 27524% Crude OR (95%CI) Adjusted OR* (95%CI)
Year (ref = 1999) † 1.03 (1.01–1.05) 1.03 (1.01–1.05)
Maternal age
<20 4.9 4.2 1.24 (1.05–1.45) 1.25 (1.06–1.48)
20–34 73.6 78.3 1.00 1.00 (Referent)
≥ 35 21.5 17.5 1.30 (1.19–1.42) 1.16 (1.06–1.27)
Parity
0 48.8 47.1 1.18 (1.09–1.28) 1.14 (1.04–1.25)
1 26.5 30.3 1 1.00 (Referent)
2 13.4 13.6 1.12 (1.00–1.28) 1.10 (0.98–1.23)
3 5.9 5.3 1.24 (1.06–1.45) 1.19 (1.01–1.40)
≥ 4 5.6 3.8 1.69 (1.43–1.99) 1.41 (1.19–1.68)
Previous caesarean 12.1 6.9 1.85 (1.66–2.07) 1.52 (1.33–1.73)
Multiple pregnancy 5.3 2.6 2.12 (1.80–2.49) 1.61 (1.35–1.92)
Malpresentation 5.3 3.1 1.68 (1.43–1.97) Not retained
Smoking 17.8 15.2 1.21 (1.10–1.32) 1.19 (1.08–1.31)
Diabetes
Pre-gestational 0.5 0.3 1.76 (1.04–2.99) Not retained
Gestational 5.3 4.4 1.19 (1.02–1.39) Not retained
Hypertension 16.3 11.6 1.49 (1.35–1.64) 1.30 (1.18–1.44)
Renal disease 0.4 0.1 2.92 (1.61–5.32) 2.76 (1.49–5.11)
Cardiac disease 1.7 0.3 5.10 (3.67–7.10) 4.13 (2.94–5.81)
Antepartum haemorrhage 8.3 2.5 3.54 (3.07–4.07) 2.53 (2.16–2.95)
Hospital type
Small rural 10.8 9.1 1.22 (1.09–1.37) 1.41 (1.26–1.59)
District 27.0 26.3 1.06 (0.97–1.15) 1.18 (1.08–1.28)
Tertiary obstetric 49.5 50.9 1.00 (Referent) 1.00 (Referent)
Private 12.7 13.7 0.96 (0.86–1.07) 0.99 (1.88–1.09)
Induction of labour 33.1 30.1 1.15 (1.07–1.24) 1.19 (1.10–1.28)
Mode of delivery
Spontaneous vaginal 54.8 70.3 1.00 (Referent) 1.00 (Referent)
Instrumental 21.1 17.2 1.59 (1.45–1.73) 1.56 (1.42–1.72)
CS prior to labour 11.4 5.7 2.60 (2.31–2.92) 1.74 (1.51–2.00)
CS during labour 12.7 6.8 2.38 (2.13–2.66) 1.99 (1.77–2.24)
Gestational age (weeks)
20–32 3.8 1.9 2.05 (1.68–2.49) 1.39 (1.13–1.72)
33–36 6.9 4.0 1.80 (1.56–2.08) 1.27 (1.09–1.48)
37+ 89.3 94.1 1.00 (Referent) 1.00 (Referent)
*Adjusted for other factors in the table as indicated; Hosmer-Lemeshow Goodness-of-Fit
P = 0.46.
† linear, for each extra year the odds ratio (OR) approximates change in rate.
CS caesarean section.BMC Pregnancy and Childbirth 2009, 9:7 http://www.biomedcentral.com/1471-2393/9/7
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(20.1%) women had at least one diagnosis indicating an
adverse outcome. The majority (84.7%) had only a single
morbid event or procedure reported, 661 (10.6%) had
two events or procedures and 293 (4.7%) had three or
more events or procedures.
The annual rate of adverse maternal outcomes increased
from 11.5 per 1000 in 1999 to 13.8 per 1000 in 2004, an
overall increase of 20.9% and a relative increase of 3.8%
per annum (95%CI 2.3–5.3%). The pregnancy and birth
factors in Table 2 did not account for this increase in
adverse maternal outcomes (data not shown). The
increase was primarily due to increases in transfusions of
blood or blood products from 682 (8.0 per 1000) in 1999
to 870 (10.7 per 1000) in 2004, a relative increase of 5.1%
per annum (95%CI 3.3%–6.9%).
Among the 6242 women with an adverse maternal out-
come the contribution of recognised predisposing risk fac-
tors was as follows: 67% of women with an adverse
outcome had an obstetric haemorrhage (60% postpartum
haemorrhage and/or 13% antepartum haemorrhage dur-
ing the birth admission), 18% had a hypertensive disor-
der, 6.1% diabetes, 3.8% cardiac disease, 0.7% renal
disease and/or 1.9% sepsis. The overall increase in adverse
maternal outcomes occurred almost entirely among
women who had a PPH (Figure 1). Although adverse out-
comes also increased among women with hypertensive
diseases (from 2.0 to 3.0%), over half these women also
had a PPH.
The rate of PPH increased significantly from 6.2% in 1999
to 6.8% in 2004 (Table 2). Most women with a PPH were
managed without the need for a transfusion or procedure
to control bleeding and hence were not considered to suf-
fer a severe PPH. Among women with PPH the rate of
adverse outcomes increased from 10.9% to 12.5%, an
overall increase of 14.3% and a relative increase of 3.1%
per annum (95%CI 1.2%–5.2%). For these women with
PPH, the risk factors associated with a adverse maternal
outcome in both univariable and multivariable analyses
included: maternal age <20 or ≥ 35 years, extremes of par-
ity, previous caesarean section, multiple pregnancy,
smoking during pregnancy, maternal medical conditions,
antepartum haemorrhage and induction of labour and
birth in a small rural hospital (Table 3). Factors that were
not predictive of adverse outcome among women with a
PPH and were excluded from the multivariable analysis
included gestation at first antenatal visit, augmentation of
labour, perineal tears, episiotomy and regional analgesia.
Overall, the decline in the number of births and in the
duration of hospital admissions resulted in a net decline
of almost 85,000 annual maternal hospital days for births
from 1999 to 2004 (Table 4). Among women with a
severe adverse outcome together with a PPH there was a
7% decrease in hospital days over the study period,
whereas women with a PPH but no severe adverse out-
come occupied 21% fewer hospital days in 2004 than in
1999. The relative decline in length of stay for women
without adverse outcomes was similar irrespective of
whether they had a PPH (Table 4).
Discussion
Our results indicate that adverse maternal outcomes asso-
ciated with childbirth are increasing in an Australian pop-
ulation and that the increase was almost entirely among
women who experienced a PPH. Significant changes in
the characteristics of women giving birth, and in obstetric
practice, did not explain the increase in severe adverse
maternal outcomes.
Internationally, studies of maternal morbidity during the
birth admission have reported incidence rates ranging
from 3.8 to 430 per 1000 deliveries [4,7,8,12,16,27].
Direct comparison is hampered by different definitions,
methods of case finding and selection of study popula-
tions. The study with a very high morbidity rate (430/
1000) was one where anything other than a normal deliv-
ery was considered a maternal morbidity including pre-
existing medical conditions and caesarean delivery [27].
Our intention was to capture, at a whole population level,
women who suffered potentially preventable adverse out-
comes, including 'near miss' events, as a measure of the
quality of care. We used an outcome indicator that would
occur with sufficient frequency to avoid random fluctua-
tions and be detectable in low-volume hospitals [11]. Like
others we have chosen to measure adverse outcomes and
not the factors that predispose to them [4,8,12,16]. For
example, although severe preeclampsia may result in sig-
nificant adverse outcomes, it can also be well managed
without adverse maternal outcome.
Trend in severe adverse maternal outcomes during the birth  admission, 1999–2004 Figure 1
Trend in severe adverse maternal outcomes during 
the birth admission, 1999–2004. * Rate of adverse out-
comes among women who had a PPH. † Rate of adverse out-
comes among women who did not have a PPH.
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The increase in maternal morbidity in this study was
attributable to the 32% increase in blood transfusions.
This is consistent with the findings of US and Scottish
studies examining trends in severe maternal morbidity
[4,12]. Callaghan and colleagues found that maternal
morbidity in the US increased by 31% from 1991 to 2003,
attributable to an increase in blood transfusions [4]. In
Scotland, severe maternal morbidity increased by 17%
from 2003 to 2005, and the increase was almost entirely
accounted for by an increase in major obstetric haemor-
rhage [12]. In contrast, a Canadian study found a stable
rate of maternal morbidity between 1991 and 2000 which
occurred in the context of comparatively low and stable
rates of postpartum haemorrhage with transfusion [8,14].
Callaghan et al considered the possibility that increasing
transfusion rates may reflect a more permissive attitude
towards blood transfusions among obstetricians or differ-
ences in medical record coding practice [4]. Rates of trans-
fusion among women with a PPH increased 5-fold in
NSW during the 1990s and a more permissive attitude was
considered a possible explanation for the increase [13,28].
However, the publication of [Australian] Clinical Practice
Guideline on the Use of Blood Components in 2001 and
initiatives to improve the appropriateness of red cell trans-
fusions has anecdotally resulted in a less permissive atti-
tude towards blood transfusion [29]. A limitation of
hospital discharge data is that the number of units trans-
fused is not available and so trends cannot be explored.
We consider changes in reporting to be an unlikely expla-
nation for the increase in transfusions in Australia. Valida-
tion studies have found transfusion reporting is accurate,
has ascertainment around 85% and has not changed over
time [11,30]. Similarly, PPH reporting has not changed
over time, with ascertainment around 74% overall and
93% for PPH requiring transfusion [21,31]. However, it
has also been suggested that there is systematic under-
reporting of haemorrhage following caesarean section.
If clinicians have been more reluctant to use blood trans-
fusions, our results suggest that not only is the PPH rate
increasing but so is the severity of the haemorrhage. Risk
factors for PPH have been thoroughly documented and
two studies have investigated the increasing rates [14,28].
Both studies found that the increase in PPH rates is not
explained by changes in known risk factors including
increasing maternal age, multiple pregnancies, caesarean
sections, placenta praevia, induction and augmentation of
labour, prolonged second stage of labour and fetal size
[14,28]. These population-based studies lacked informa-
tion on some obstetric practices, such as management of
the third stage of labour and monitoring in the early post-
partum period, and inadequacy of these practices may be
an explanation for the increase in PPH.
Active management of the third stage of labour is effective
in reducing PPH and the burden of disease associated
with haemorrhage [32]. The International Confederation
of Midwives and the International Federation of Gynecol-
ogists and Obstetricians (ICM/FIGO) recommend active
management of the third stage of labor for all women
[33]. However, adherence with active third-stage manage-
ment recommendations is poorly reported and/or subop-
timal in Australia, and significant variations in policies
and practice have been reported elsewhere [33-35]. Sub-
optimal adherence with active management guidelines
could explain rising PPH rates.
We identified a number of risk factors for severe adverse
maternal outcomes among women who suffer a PPH,
although the effect of the more distal risk factors, such as
prior caesarean section, may be under-estimated (see
methods). Factors that commonly occur in the population
and have a moderate risk (eg induction of labour and
operative deliveries) will make a greater population con-
tribution to adverse outcomes than rare exposures with
markedly elevated risks (eg renal and cardiac disease). The
non-specific nature of the risk factors for adverse maternal
outcomes among women with a PPH reinforces the prop-
osition that management and monitoring protocols for
the early identification and prevention of PPH should
focus on all women not just those considered to be at risk
[36].
The risk factor for PPH-associated adverse outcomes that
is most amenable to intervention is place of birth. After
Table 4: Decline in duration of the birth admission in NSW from 1999 to 2004, by occurrence of adverse maternal outcome and 
postpartum haemorrhage (PPH)
Total length of stay (days)
1999 (84,934 women) 2004 (81,381 women) Decline in length of stay 1999–2004 No of days
(% change)
All women 364,820 280,238 -84,582 (-23.2%)
No severe morbidity 357,745 274,039 -83,706 (-23.4%)
PPH, no severe morbidity 21,220 16,812 -4,408 (-20.8%)
Any severe morbidity 7,075 6,199 -876 (-12.4%)
PPH with severe morbidity 3,782 3,508 -274 (-7.2%)BMC Pregnancy and Childbirth 2009, 9:7 http://www.biomedcentral.com/1471-2393/9/7
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adjusting for casemix, women with a PPH at a small rural
hospital were over 40% more likely to suffer an adverse
maternal outcome than women delivering at a tertiary
obstetric hospital. Maternity services in rural areas need to
be resourced with adequate staff, skills and facilities to
manage PPH. A survey of the uptake of a PPH prevention
and management policy in NSW reported inadequate
postpartum monitoring (blood loss, fundal tone, pulse,
blood pressure) of women, especially in small rural hos-
pitals, and that staff shortages were a barrier to imple-
menting the policy[37] ICM/FIGO recommends careful
observation and monitoring every 15 minutes during the
first 2 hours following delivery, with palpation of the
uterus (and massage if necessary) [36]. In view of the
potential hazard of bleeding due to uterine atony, genital
tract trauma and retained products of conception, there is
an urgent need to standardise, implement and resource a
policy of careful observation and monitoring in the 2-
hour period following delivery.
Whilst all women should be regarded as being at risk of
haemorrhage, our findings suggest that some women can
be identified antenatally (eg those with prior caesarean
section, multiple pregnancy, renal or cardiac disease) as
having a substantially increased relative risk of an adverse
outcome if a PPH occurs, and these risk factors merit con-
sideration of a higher level of obstetric care for delivery
and increased vigilance postpartum.
The short and long term consequences of adverse mater-
nal outcomes can be profound including surgery, emer-
gency care, infertility, psychological effects, disability and
even death. Although the number of days in hospital rep-
resent the 'tip of the iceberg' for costs to women and the
health system, they provide a snapshot of the impact of
adverse maternal outcomes on the health system. Overall
the number of days spent in hospital at the time of deliv-
ery declined by 23%, although the number of women giv-
ing birth decreased by only 4.2%. For women with a
severe adverse outcome, however, the decline in bed-days
was much lower (12% overall and 7% among those with
PPH) indicating that the impact of adverse maternal out-
comes are relatively intractable and that costs could be
better reduced by prevention than improved management
after the event.
The major strength of this population-based cohort study
is the use of outcome and exposure measures that are
accurately and reliably reported in population health
data. The development and validation of the MMOI has
been described in detail elsewhere [11]. Briefly, the study
had three phases: first conditions and procedures that
could comprise a severe maternal morbidity indicator
were catalogued by reviewing the literature and consulting
with clinicians; second, was a validation study of the ini-
tial indicator by review of the medical records; and finally
adverse outcomes, as determined from the medical record
review, was used to refine the initial indicator to give an
MMOI that identified severe adverse maternal outcomes
from the population health data with a high positive pre-
dictive value (95%). Although the number of available
diagnosis or procedure fields in each medical record
increased over the study period, the MMOI was applied to
the same number of fields each year to ensure that any
increase in adverse maternal outcome was not attributable
to greater ascertainment. Furthermore, the availability of
linked birth and hospital data obviates the need for com-
plex algorithms to identify birth admissions in hospital
discharge data [38].
As this study is limited to the birth admission, and does
not include postpartum admissions, it could result in
under-ascertainment of adverse maternal outcomes.
Because the timing of events during the hospital admis-
sion can generally not be obtained from hospital dis-
charge data, causal pathways to adverse maternal outcome
may also be uncertain. However, haemorrhage is consist-
ently reported as the largest and most important cause of
maternal morbidity [4,10-12].
Caution is needed in interpreting the incidence of the
individual components of the MMOI. A significant advan-
tage of a composite outcome indicator is that it helps to
overcome the recognised under-ascertainment of individ-
ual diagnoses and procedures in routinely collected data
[11]. For example, we have found under-reporting of cae-
sarean hysterectomy in hospital data, possibly because the
procedure is rarely a planned procedure [11]. However,
women requiring a hysterectomy to control bleeding usu-
ally receive a blood transfusion and/or other procedures
to control bleeding [11,39]. These procedures are well
ascertained and as long as one is recorded, these women
will be indentified by the MMOI.
Conclusion
In summary, we found that 1 in 80 women giving birth in
Australia suffered a severe adverse outcome during child-
birth and this rate rose to 1 in 8 women who had a PPH.
Reducing or stabilising the increasing PPH rates would
halt the increase in maternal morbidity. Ensuring that all
women who give birth have access to active management
of the third stage of labour and careful observation in the
first 2 hours after delivery may reduce the PPH rate and
the potential for severe morbidity and death.
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